Keyphrases
Bone Cancer Pain
66%
Analgesic
41%
Chronic Pain
41%
P2X7 Receptor (P2X7R)
33%
Trifluoromethyl
33%
Gene-deficient Mice
33%
Bone Remodeling
33%
Dioxo
33%
A-317491
33%
P2X3 Receptor
33%
P2X3
33%
GABAA
33%
GluK1
33%
Primary Hyperparathyroidism (pHPT)
33%
Public Acceptance
33%
Positive Allosteric Modulation
33%
Capsaicin
33%
Innervation
33%
Positive Allosteric Modulator
33%
Selective Antagonist
33%
Risedronate
33%
Nerve
33%
X-ray Crystallography
33%
Human Bone
33%
Astrocytes
33%
Bone Pain
33%
Modulated Potential
33%
Phosphonocarboxylate
33%
Cancer Treatment-induced Bone Loss
33%
Low-dose Treatment
33%
Cannabinoid Agonists
33%
In Vitro Pharmacology
33%
Structure-affinity Relationships
33%
Benzamide
33%
Kainate Receptor
33%
Nondisease Condition
33%
Drug Use
33%
Compound B
33%
PNU-120596
33%
Inflammatory Hyperalgesia
33%
Pain Behavior
26%
Kainate
22%
AMPA Receptor (AMPAR)
22%
Tool Compound
16%
Disease-modifying Agents
16%
TPA023
16%
NS11394
16%
Bone Cancer Pain Model
16%
Mechanical Hypersensitivity
16%
Drug Type
16%
Medicine and Dentistry
Bone Pain
100%
Allosteric Modulator
66%
GABAA Receptor
66%
Receptor
43%
Innervation
41%
Bone Cancer
36%
Calcitonin Gene Related Peptide
33%
Cytokine Release
33%
Osteoplasty
33%
Chronic Drug Administration
33%
Primary Hyperparathyroidism
33%
Carrageenan
33%
Hyperpathia
33%
Capsaicin
33%
Receptor Modulation
33%
Diclofenac
33%
Nonsteroid Antiinflammatory Agent
33%
Pain Medicine
33%
Bone Remodeling
33%
Hypersensitivity
33%
Malignant Neoplasm
33%
Diseases
33%
Inflammatory Pain
29%
Analgesia
18%
Purinergic P2X3 Receptor
16%
Gene Product
16%
Tyrosine 3 Monooxygenase
16%
Blood Vessel
16%
Interleukin 6
16%
Nerve Fiber
16%
Formaldehyde
16%
Mechanical Hyperalgesia
16%
Freund's Adjuvant
16%
Nicotinic Receptor
16%
Gamma-Aminobutyric Acid
15%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Cancer
100%
Receptor
78%
Malignant Neoplasm
70%
4 Aminobutyric Acid
66%
Positive Allosteric Modulator
66%
Cancer Pain
38%
Bone Pain
38%
Inflammatory Pain
35%
Diclofenac
33%
Carrageenan
33%
Receptor Agonist
33%
Purinergic P2X7 Receptor
33%
Risedronic Acid
33%
Cannabinoid
33%
WIN 55,212-2
33%
Erethism
33%
Cytokine
33%
Pain Medicine
33%
Capsaicin
33%
Calcitonin Gene Related Peptide
33%
Hyperalgesia
33%
Non-Steroidal Anti-Inflammatory Drug
25%
Purinergic P2X3 Receptor
16%
Mechanical Hyperalgesia
16%
Freund's Adjuvant
16%
Interleukin 6
16%
Nicotinic Receptor
16%
Formaldehyde
16%
Bisphosphonic Acid Derivative
16%
